United Therapeutics valuation

UTHR · NASDAQ · USD

Compare United Therapeutics
$584.10Change from previous close: −0.64%Absolute change: −$3.78

Close · November 17, 2026

Valuation

The P/E ratio is 22.2. The average price target of 14 analysts is $687.14.

Data as of November 17, 2026

United Therapeutics compared with similar companies

United Therapeutics's P/E (trailing 12 months): 22.2, −20% against the median of a group of 9 similar companies (27.6).

United Therapeutics's metrics compared with similar companies
MetricUnited TherapeuticsMedian25th–75th percentileBand
P/E (trailing 12 months)22.227.622.2 – 78.9Middle
Forward P/E17.020.914.4 – 40.1Middle
EV/EBITDA17.017.014.2 – 33.0Middle
Price/book3.977.944.38 – 11.3Low
Price/sales7.856.193.74 – 12.1Middle
Gross margin86.3%73.8%64.7% – 85.2%High
Operating margin39.4%32.8%23.3% – 37.8%High
Net margin38.6%27.0%13.9% – 37.6%High
ROE19.1%19.3%15.3% – 20.3%Middle

Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.

TickerLandia analysisHow it is calculated

Companies in the group: same industry, similar size

United Therapeutics: valuation over time

On the latest fiscal year's earnings (2025), United Therapeutics's P/E today is 20.8, above the median of its last 9 fiscal years (14.3; between 8.13 and 21.5 from 2016 to 2025). Relative to earnings, the stock costs more than it used to.

United Therapeutics P/E and dividend yield at each fiscal year end
Fiscal yearPrice at year endEarnings per shareP/E
2025$487.25$27.8617.5
2024$352.84$24.6414.3
2023$219.89$19.8111.1
2022$278.09$15.0018.5
2021$216.08$10.0621.5
2020$151.79$11.5413.2
2019$88.08-$2.39—
2018$108.90$13.398.13
2017$147.95$9.3115.9
2016$143.43$15.259.41

TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only). Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above.

TickerLandia analysisHow it is calculated

Other metrics

Valuation multiples

Market cap
$25.04B
Enterprise value
$22.97B
PEG
2.22
EV/revenue
7.21

Profitability and growth

ROA
10.9%
Revenue growth (year over year)
4.1%
Earnings growth (year over year)
-20.3%

Financial health

Total cash
$2.07B
Total debt
$0
Current ratio
4.61
Quick ratio
3.87

Dividends

Dividend yield
0.0%
Payout ratio
0.0%

Analysts and estimates

Average price target
$687.14
Median price target
$711.50
High price target
$850.00
Low price target
$390.00
Analysts with a price target
14
Consensus
Buy
Forward EPS
$34.62
EPS estimate, current year
$24.96

Shares and trading

Beta
0.48
Average volume
703.57K
Shares outstanding
42.59M
Float
38.91M
Institutional ownership
102.1%
Insider ownership
2.5%
Short interest (% of float)
5.0%
Short ratio (days)
2.12